INS and cancer: In addition to the potential for endocrine control of aging by insulin, signaling through insulin-like pathways is also a major factor in the development of cancer and diabetes, both of which have increased incidence at older ages (Saltiel & Kahn, 2001; Osaki et al., 2004).